Last reviewed · How we verify
Partial Epilepsy Treatment Adjunct
Approved treatments
- Keppra · Masonic Cancer Center, University of Minnesota
- Vimpat · UCB
- Tranxene · Ajenat Pharms
- Keppra · Generic (originally UCB Pharma)
Levetiracetam binds to synaptic vesicle protein SV2A, potentially regulating vesicle exocytosis. - Neurontin · Generic (originally Parke-Davis/Pfizer)
Binds the alpha-2-delta subunit of voltage-gated calcium channels, modulating neurotransmitter release to treat neuropathic pain and seizures. - Zonegran · Dr. Reddy's Laboratories Limited
- gabapentine · Dominik Irnich
- Retigabine · Bausch Health Americas, Inc.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Partial Epilepsy Treatment Adjunct patent landscape — cliff calendar, originator estates, attackable patents
- Partial Epilepsy Treatment Adjunct treatment landscape brief
- Partial Epilepsy Treatment Adjunct treatment updates RSS
Frequently asked questions about Partial Epilepsy Treatment Adjunct
What drugs treat Partial Epilepsy Treatment Adjunct?
Tracked treatments include Keppra, Vimpat, Tranxene, Neurontin, Zonegran, gabapentine, Retigabine.
What is the treatment for Partial Epilepsy Treatment Adjunct?
Standard treatment for Partial Epilepsy Treatment Adjunct includes Keppra, Vimpat, Tranxene, Neurontin, Zonegran. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Partial Epilepsy Treatment Adjunct patent cliff · Partial Epilepsy Treatment Adjunct CI report
- Treatment: Keppra · Masonic Cancer Center, University of Minnesota
- Treatment: Vimpat · UCB
- Treatment: Tranxene · Ajenat Pharms
- Treatment: Keppra · Generic (originally UCB Pharma)
- Treatment: Neurontin · Generic (originally Parke-Davis/Pfizer)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing